Latest Pivotal bioVenture Partners Investment Advisor LLC Stock Portfolio
Pivotal bioVenture Partners Investment Advisor LLC Performance:
2025 Q3: 13.11%YTD: -10.04%2024: 22.7%
Performance for 2025 Q3 is 13.11%, and YTD is -10.04%, and 2024 is 22.7%.
About Pivotal bioVenture Partners Investment Advisor LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Pivotal bioVenture Partners Investment Advisor LLC reported an equity portfolio of $173 Millions as of 30 Sep, 2025.
The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are PCVX, , ARQT. The fund has invested 28.6% of it's portfolio in VAXCYTE INC and 23.4% of portfolio in OCULIS HOLDING AG.
The fund managers got completely rid off INOZYME PHARMA INC (INZY), VIGIL NEUROSCIENCE INC (VIGL) and IO BIOTECH INC (IOBT) stocks. Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in IMMUNOME INC (IMNM). The fund showed a lot of confidence in some stocks as they added substantially to TREVI THERAPEUTICS INC (TRVI) and VAXCYTE INC (PCVX).
The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are PCVX, , ARQT. The fund has invested 28.6% of it's portfolio in VAXCYTE INC and 23.4% of portfolio in OCULIS HOLDING AG.
The fund managers got completely rid off INOZYME PHARMA INC (INZY), VIGIL NEUROSCIENCE INC (VIGL) and IO BIOTECH INC (IOBT) stocks. Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in IMMUNOME INC (IMNM). The fund showed a lot of confidence in some stocks as they added substantially to TREVI THERAPEUTICS INC (TRVI) and VAXCYTE INC (PCVX).
Pivotal bioVenture Partners Investment Advisor LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Pivotal bioVenture Partners Investment Advisor LLC made a return of 13.11% in the last quarter. In trailing 12 months, it's portfolio return was -22.31%.
New Buys
| Ticker | $ Bought |
|---|---|
| immunome inc | 5,884,420 |
New stocks bought by Pivotal bioVenture Partners Investment Advisor LLC
Additions
| Ticker | % Inc. |
|---|---|
| trevi therapeutics inc | 9.66 |
| vaxcyte inc | 5.16 |
Additions to existing portfolio by Pivotal bioVenture Partners Investment Advisor LLC
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| inozyme pharma inc | -17,979,400 |
| io biotech inc | -1,201,230 |
| vigil neuroscience inc | -4,456,730 |
Pivotal bioVenture Partners Investment Advisor LLC got rid off the above stocks
Sector Distribution
Pivotal bioVenture Partners Investment Advisor LLC has about 64.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 64.4 |
| Others | 35.6 |
Market Cap. Distribution
Pivotal bioVenture Partners Investment Advisor LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 35.6 |
| MID-CAP | 28.6 |
| SMALL-CAP | 28.2 |
| MICRO-CAP | 7.3 |
Stocks belong to which Index?
About 60.7% of the stocks held by Pivotal bioVenture Partners Investment Advisor LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 60.7 |
| Others | 39.3 |
Pivotal bioVenture Partners Investment Advisor LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Pivotal bioVenture Partners Investment Advisor LLC
Pivotal bioVenture Partners Investment Advisor LLC has 10 stocks in it's portfolio. RXRX proved to be the most loss making stock for the portfolio. ARQT was the most profitable stock for Pivotal bioVenture Partners Investment Advisor LLC last quarter.
Last Reported on: 13 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ARQT | arcutis biotherapeutics inc | 23.11 | 2,120,510 | 39,971,600 | unchanged | 0.00 | ||
| BOLT | bolt biotherapeutics inc | 0.29 | 94,573 | 503,128 | unchanged | 0.00 | ||
| IMNM | immunome inc | 3.40 | 502,512 | 5,884,420 | new | |||
| INZY | inozyme pharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| IOBT | io biotech inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PCVX | vaxcyte inc | 28.58 | 1,372,420 | 49,434,700 | added | 5.16 | ||
| RLYB | rallybio corp | 0.69 | 2,404,640 | 1,199,920 | unchanged | 0.00 | ||
| RXRX | recursion pharmaceuticals in | 1.68 | 595,518 | 2,906,130 | unchanged | 0.00 | ||
| TRVI | trevi therapeutics inc | 6.65 | 1,256,780 | 11,499,600 | added | 9.66 | ||
| VIGL | vigil neuroscience inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| oculis holding ag | 23.38 | 2,300,770 | 40,447,600 | unchanged | 0.00 | |||
| zenas biopharma inc | 10.00 | 779,045 | 17,294,800 | unchanged | 0.00 | |||
| bioage labs inc | 2.22 | 653,374 | 3,841,840 | unchanged | 0.00 | |||